NYSE:PRGO - Perrigo Stock Price, News, & Analysis

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Perrigo announced a quarterly dividend on Wednesday, October 31st. Investors of record on Friday, November 30th will be paid a dividend of $0.19 per share on Tuesday, December 18th. This represents a $0.76 dividend on an annualized basis and a yield of 1.20%. The ex-dividend date of this dividend is Thursday, November 29th. View Perrigo's Dividend History.

Perrigo Company PLC (NYSE:PRGO) issued its quarterly earnings data on Thursday, November, 8th. The company reported $1.09 earnings per share for the quarter, topping analysts' consensus estimates of $1.05 by $0.04. The company had revenue of $1.13 billion for the quarter, compared to analysts' expectations of $1.17 billion. Perrigo had a return on equity of 11.32% and a net margin of 2.54%. The business's quarterly revenue was down 8.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.39 earnings per share. View Perrigo's Earnings History.

Perrigo is scheduled to release their next quarterly earnings announcement on Thursday, March 7th 2019. View Earnings Estimates for Perrigo.

Perrigo issued an update on its FY18 earnings guidance on Thursday, November, 8th. The company provided EPS guidance of $4.45-4.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.86. The company issued revenue guidance of ~$4.72 billion, compared to the consensus revenue estimate of $4.87 billion.Perrigo also updated its FY 2018 guidance to $4.45-4.65 EPS.

15 analysts have issued 12 month price targets for Perrigo's stock. Their forecasts range from $63.00 to $110.00. On average, they anticipate Perrigo's share price to reach $82.7333 in the next year. This suggests a possible upside of 30.8% from the stock's current price. View Analyst Price Targets for Perrigo.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 1 sell rating, 11 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Perrigo.

News stories about PRGO stock have trended very positive this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Perrigo earned a media sentiment score of 4.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future.

Some companies that are related to Perrigo include Takeda Pharmaceutical (TKPYY), ASTELLAS PHARMA/ADR (ALPMY), Alexion Pharmaceuticals (ALXN), Shiseido (SSDOY), Teva Pharmaceutical Industries (TEVA), Mylan (MYL), BioMarin Pharmaceutical (BMRN), UCB (UCBJF), Ono Pharmaceutical (OPHLF), Merck KGaA (MKGAF), GRIFOLS S A/S (GRFS), Bausch Health Companies (BHC), Jazz Pharmaceuticals (JAZZ), Genmab A/S (GNMSF) and Sarepta Therapeutics (SRPT).

Perrigo's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include FMR LLC (8.10%), Franklin Resources Inc. (6.79%), BlackRock Inc. (6.08%), Brown Brothers Harriman & Co. (4.13%), Victory Capital Management Inc. (2.29%) and Ceredex Value Advisors LLC (2.07%). Company insiders that own Perrigo stock include Geoffrey M Parker, Jeffrey C Smith, Jeffrey Needham, John Wesolowski, Judy L Brown, Murray S Kessler, Sharon Kochan, Svend Andersen, Thomas Farrington, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo.

PRGO stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Los Angeles Capital Management & Equity Research Inc., BlackRock Inc., Brown Brothers Harriman & Co., Deutsche Bank AG, Migdal Insurance & Financial Holdings Ltd., Crawford Investment Counsel Inc. and Panagora Asset Management Inc.. Company insiders that have sold Perrigo company stock in the last year include John Wesolowski and Todd W Kingma. View Insider Buying and Selling for Perrigo.

PRGO stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Iridian Asset Management LLC CT, Ceredex Value Advisors LLC, Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management, First Eagle Investment Management LLC, Nordea Investment Management AB, Franklin Resources Inc. and Victory Capital Management Inc.. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, John Wesolowski, Murray S Kessler, Svend Andersen, Todd W Kingma and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo.

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PRGO stock can currently be purchased for approximately $63.27.

Perrigo has a market capitalization of $8.60 billion and generates $4.95 billion in revenue each year. The company earns $119.60 million in net income (profit) each year or $4.93 on an earnings per share basis. Perrigo employs 10,400 workers across the globe.

The official website for Perrigo is http://www.perrigo.com.

Perrigo's mailing address is TREASURY BUILDING LOWER GRAND CANAL STREET, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]